Jazz Pharmaceuticals (JAZZ)

JAZZ trades at $139.48, 21.3% above the near-term max pain of $115 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($115-$130), signaling increased put positioning or downside protection. Key magnetic zone at 115 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for JAZZ shows a downward trend from 130 to 115, indicating bearish sentiment or hedging activity. The 13% spread signals divergent expectations across timeframes. Most levels below 139.48 may cap rallies. Strong magnetic level at 115 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.